Advertisement

Pharmacy

U.S. House progressive caucus members invited executives from six pharma companies to testify on Capitol Hill next week about what the lawmakers deem "unjustifiable" price increases, according to STAT news.

While a large majority of hospitals obtain non-patient specific compounded drugs from FDA-designated outsourcing facilities, 11 percent of them obtained drugs from unregistered compounders, according to a new report from the HHS Office of the Inspector General.

Zolgensma, recently approved by the FDA, tops GoodRx's list of the 10 most expensive drugs in the U.S., with a $2.1 million price tag.

Advertisement

Nine pharmaceutical companies or suppliers that filed for bankruptcy since Jan. 1, as reported by Becker's Hospital Review:

Catalyst Pharmaceuticals has sued the FDA, accusing the agency of violating provisions of the law and its rights to exclusivity for its rare disease drug Firdapse when it approved a lower-cost rival drug, according to healthcare news website STAT.

Florida Gov. Ron DeSantis signed a bill to create a program to import prescription drugs from Canada and another program that would authorize importation from other countries as well, according to the Tampa Bay Times.

Advertisement